WHAT WE DO
Axitan is focused on and driven towards developing and commercialising a unique range of microalgae based biologics targeted at the $30 billion per annum animal health industry.
Microalgae constitutes the perfect vaccine delivery system, instead of manually injecting hundreds of millions of animals each year, our products are simply incorporated into their feed. What’s more, they are sustainable and environmentally friendly and have none of negative side effects associated with traditional antibiotics. Our strains have been precision engineered to produce proteins which, when consumed by the animal, help it to stay healthy, significantly reducing the cost and burden of disease. The proteins are completely safe for both the animal, the environment and for you. What’s more, by naturally ‘bioencapsulating’ the proteins within the microalgae, they are shielded from the harsh environment found in the animal’s stomach, ensuring that they retain their activity by the time they reach the intestine. They also have the added advantage of being incredibly temperature stable, thus eliminating the need for refrigerated transportation. This helps to reduce costs even further and enables us to reach out to the worlds less economically developed regions. Whilst we believe our technology can be applied to most production and companion animals, we are currently working on treatments for the poultry and aquaculture industry. We feel that as the price per animal drops the need for a cost effective and easy to administer treatment increases.
THE BIG PICTURE
By the year 2050, the world will need to double food production to feed an estimated global population of 9.7 billion. We are going to need at least 70% more protein than what is available to humankind today. This challenge is simply staggering.
Many of today’s food production practices are unsustainable. For example, the overuse of antibiotics in livestock is a hugely problematic and has been a significant contributing factor in the emergence of bacterial antibiotic resistance. Whilst the direct healthcare costs of this are hard to estimate, In the US alone they have ranged as high as $20 billion a year and kill more than 700,000 people worldwide. A major advantage of Axitan’s microalgae based technology is it reduces the demand for antibiotics. Approximately 70% of the diseases known to affect humans are zoonotic, meaning that can be transmitted between animals and humans, so keeping our animals healthy also helps to keep us healthy. Through the use of vaccines, medicines, feed additives and improved production practices, our earth’s scarce resources and our own health can be better managed, enabling us to live longer healthier lives.